Analyst Price Targets — ABEO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 17, 2026 8:31 am | — | Roth Capital | $17.00 | $5.37 | TheFly | Abeona Therapeutics initiated with a Buy at Roth Capital |
| August 14, 2026 4:13 pm | — | Industrial Alliance Securities | $15.00 | $5.90 | TheFly | Abeona Therapeutics price target lowered to $15 from $20 at Alliance Global |
| August 14, 2026 12:08 pm | Jeff Jones | Oppenheimer | $21.00 | $6.04 | TheFly | Abeona Therapeutics price target lowered to $21 from $22 at Oppenheimer |
| March 17, 2026 7:53 pm | Stephen Willey | Stifel Nicolaus | $17.00 | $4.76 | StreetInsider | Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates |
| May 16, 2025 12:02 pm | Stephen Willey | Stifel Nicolaus | $20.00 | $6.10 | TheFly | Abeona Therapeutics price target lowered to $20 from $21 at Stifel |
| March 5, 2025 12:18 pm | — | Oppenheimer | $16.00 | $5.26 | TheFly | Abeona Therapeutics initiated with an Outperform at Oppenheimer |
| November 14, 2022 1:42 pm | — | Leerink Partners | $6.00 | $4.15 | Benzinga | SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6 |
Latest News for ABEO
Abeona Therapeutics Inc. (NASDAQ:ABEO) had a busy week that included a new treatment center activation, an FDA approval for a drug the company licensed away and multiple fresh analyst ratings.
- FDA approval represents a monumental milestone for patients with MPS IIIA and validates Abeona's foundational R&D and clinical development efforts -
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO).
Abeona Therapeutics Inc. (ABEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced the activation of University of Florida Health (UF Health) in Gainesville, Florida, as the eighth Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel)…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ABEO.
U.S. House Trading
No House trades found for ABEO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.